Mesenchymal stem cells and IL-37: a powerful combination.
IL-37
inflammation
mesenchymal stem cells
Journal
Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253
Informations de publication
Date de publication:
Historique:
entrez:
27
7
2019
pubmed:
28
7
2019
medline:
1
8
2019
Statut:
ppublish
Résumé
Mesenchymal stem cells (MSCs) are able to exert immunomodulatory and anti-inflammatory actions. Thanks to these properties, MSCs may be a promising alternative approach for the treatment of inflammatory disease. Important cytokines involved in inflammation are those included in the IL-1 family. Interleukin-37 (IL-37) is one of the member able to suppress both innate and adaptive immunity. Recently, it was found that MSCs and their derivatives can modulate IL-37, and MSCs expressing IL-37 seem to have an enhanced therapeutic efficacy.
Substances chimiques
Cytokines
0
IL37 protein, human
0
Interleukin-1
0
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1019-1022Informations de copyright
Copyright 2019 Biolife Sas. www.biolifesas.org.